<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Aesthetics Product Guide &#187; Vision</title>
	<atom:link href="http://blog.aestheticsproductguide.com/category/vision/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.aestheticsproductguide.com</link>
	<description>A comprehensive guide to aesthetics products for medical professionals</description>
	<lastBuildDate>Mon, 27 Sep 2010 15:54:09 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>FDA Warns Of Possible Dangers From Portable Foot-Tanning Device</title>
		<link>http://blog.aestheticsproductguide.com/2010/08/30/fda-warns-of-possible-dangers-from-portable-foot-tanning-device/</link>
		<comments>http://blog.aestheticsproductguide.com/2010/08/30/fda-warns-of-possible-dangers-from-portable-foot-tanning-device/#comments</comments>
		<pubDate>Mon, 30 Aug 2010 09:58:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[FDA Approval]]></category>
		<category><![CDATA[Vision]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[tanning device]]></category>
		<category><![CDATA[Tootsie Tanner]]></category>
		<category><![CDATA[ultraviolet radiation]]></category>
		<guid isPermaLink="false">http://www.aestheticsproductguide.com/blog/?p=316</guid>
		<description><![CDATA[The FDA is warning consumers about the risk of ultraviolet radiation overdose with the Tootsie Tanner portable foot tanning device. Use of the tanning device can lead to an overdose of ultraviolet radiation because its labeling recommends an improper duration of exposure to radiation and the device has an inadequate timer. The labeled exposure schedule [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.aestheticsproductguide.com/files/2010/08/ultraviolet-radiation.png"><img class="alignright size-full wp-image-317" style="margin: 5px" src="http://blog.aestheticsproductguide.com/files/2010/08/ultraviolet-radiation.png" border="0" alt="ultraviolet radiation" width="200" height="143" /></a>The FDA is warning consumers about the risk of ultraviolet radiation overdose with the Tootsie Tanner portable foot tanning device. Use of the tanning device can lead to an overdose of ultraviolet radiation because its labeling recommends an improper duration of exposure to radiation and the device has an inadequate timer. The labeled exposure schedule indicates that the device may be used for 30 minutes, and the timer control permits 30 minutes exposure.</p>
<p>Read the full story <a href="http://www.medicalnewstoday.com/articles/198868.php" target="_blank">here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blog.aestheticsproductguide.com/2010/08/30/fda-warns-of-possible-dangers-from-portable-foot-tanning-device/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bausch And Lomb Introduces The Stellaris(R) PC Vision Enhancement System</title>
		<link>http://blog.aestheticsproductguide.com/2010/08/10/bausch-and-lomb-introduces-the-stellarisr-pc-vision-enhancement-system/</link>
		<comments>http://blog.aestheticsproductguide.com/2010/08/10/bausch-and-lomb-introduces-the-stellarisr-pc-vision-enhancement-system/#comments</comments>
		<pubDate>Tue, 10 Aug 2010 07:57:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Vision]]></category>
		<category><![CDATA[Bausch + Lomb]]></category>
		<category><![CDATA[cataract surgery]]></category>
		<category><![CDATA[phacoemulsification]]></category>
		<category><![CDATA[Stellaris(R) PC]]></category>
		<category><![CDATA[Vision Enhancement System]]></category>
		<category><![CDATA[vitrectomy]]></category>
		<guid isPermaLink="false">http://www.aestheticsproductguide.com/blog/?p=297</guid>
		<description><![CDATA[Bausch + Lomb has announced the worldwide launch of the Stellaris(R) PC (Procedural Choice) Vision Enhancement System. The new combined vitrectomy and phacoemulsification system allows surgeons to have true &#8220;procedural choice&#8221; by providing the most advanced technology for both vitreoretinal and cataract surgery in a single system. The new Stellaris PC provides a high-performance, combined [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.aestheticsproductguide.com/files/2010/08/Bausch-And-Lomb.png"><img class="alignright size-full wp-image-298" style="margin: 5px" src="http://blog.aestheticsproductguide.com/files/2010/08/Bausch-And-Lomb.png" border="0" alt="Bausch And Lomb" width="200" height="46" /></a>Bausch + Lomb has announced the worldwide launch of the Stellaris(R) PC (Procedural Choice) Vision Enhancement System. The new combined vitrectomy and phacoemulsification system allows surgeons to have true &#8220;procedural choice&#8221; by providing the most advanced technology for both vitreoretinal and cataract surgery in a single system. The new Stellaris PC provides a high-performance, combined experience that leverages Bausch + Lomb&#8217;s history in retinal innovation with the demonstrated excellence of the Stellaris phacoemulsification platform.</p>
<p>Read the full story <a href="http://www.medicalnewstoday.com/articles/197114.php" target="_blank">here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blog.aestheticsproductguide.com/2010/08/10/bausch-and-lomb-introduces-the-stellarisr-pc-vision-enhancement-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sales of HydroPeptide soaring</title>
		<link>http://blog.aestheticsproductguide.com/2009/09/29/sales-of-hydropeptide-soaring/</link>
		<comments>http://blog.aestheticsproductguide.com/2009/09/29/sales-of-hydropeptide-soaring/#comments</comments>
		<pubDate>Tue, 29 Sep 2009 05:35:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Hair Replacement]]></category>
		<category><![CDATA[Vein Treatments]]></category>
		<category><![CDATA[Vision]]></category>
		<category><![CDATA[eye inflammation]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[HydroPeptide]]></category>
		<category><![CDATA[lash product]]></category>
		<category><![CDATA[Latisse]]></category>
		<category><![CDATA[Lilash]]></category>
		<category><![CDATA[macular edema]]></category>
		<category><![CDATA[MD Lash Factor]]></category>
		<category><![CDATA[Peter Thomas Roth Lashes To Die for]]></category>
		<category><![CDATA[swelling of retina]]></category>
		<category><![CDATA[uveitis]]></category>
		<guid isPermaLink="false">http://www.aestheticsproductguide.com/blog/?p=161</guid>
		<description><![CDATA[HydroPeptide Lash Longer Fuller Lusher is rapidly gaining popularity in the US as the new lash product due to its drug-free formulation and impressive results. HydroPeptide Lash’s popularity is partly due to the fact that the product does not contain “glaucoma type meds” like Latisse®, Peter Thomas Roth Lashes To Die for, Lilash or MD [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.aestheticsproductguide.com/files/2009/09/hydropeptide.png"><img class="alignright size-full wp-image-162" style="margin: 5px" src="http://blog.aestheticsproductguide.com/files/2009/09/hydropeptide.png" alt="hydropeptide" width="200" height="445" /></a>HydroPeptide Lash Longer Fuller Lusher is rapidly gaining popularity in the US as the new lash product due to its drug-free formulation and impressive results. HydroPeptide Lash’s popularity is partly due to the fact that the product does not contain “glaucoma type meds” like Latisse®, Peter Thomas Roth Lashes To Die for, Lilash or MD Lash Factor. The FDA is taking action against the other products because the “use of Age Intervention Eyelash may cause other adverse effects in certain people due to the bimatoprost, including macular edema (swelling of the retina) and uveitis (inflammation in the eye), which may lead to decreased vision.”</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.aestheticsproductguide.com/2009/09/29/sales-of-hydropeptide-soaring/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>China approves STAAR Toric and Hyperopic ICL</title>
		<link>http://blog.aestheticsproductguide.com/2008/03/03/china-approves-staar-toric-and-hyperopic-icl/</link>
		<comments>http://blog.aestheticsproductguide.com/2008/03/03/china-approves-staar-toric-and-hyperopic-icl/#comments</comments>
		<pubDate>Mon, 03 Mar 2008 19:24:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Vision]]></category>
		<category><![CDATA[China State Food and Drug Adminstration]]></category>
		<category><![CDATA[Hyperopic ICL]]></category>
		<category><![CDATA[Implantable Collamer Lens]]></category>
		<category><![CDATA[lens]]></category>
		<category><![CDATA[SFDA]]></category>
		<category><![CDATA[STAAR]]></category>
		<category><![CDATA[Toric ICL]]></category>
		<guid isPermaLink="false">http://www.aestheticsproductguide.com/blog/2008/03/03/china-approves-staar-toric-and-hyperopic-icl/</guid>
		<description><![CDATA[STAAR Surgical Company has been given the green light from China’s State Food and Drug Administration (SFDA) to market its minimally invasive ICL (Implantable Collamer Lens) products. The Visian Toric ICL has been approved for treating nearsightedness and astigmatism, while the Visian Hyperopic ICL, or Visian ICH, has been approved for correcting hyperopia or farsightedness. [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.staar.com/">STAAR Surgical Company</a> has been give<img border="1" vspace="5" align="right" width="119" src="http://blog.aestheticsproductguide.com/files/2008/03/implantable-collamer-lens.jpg" hspace="5" alt="Implantable Collemer Lens" height="109" />n the green light from China’s State Food and Drug Administration (SFDA) to market its minimally invasive ICL (Implantable Collamer Lens) products. The Visian Toric ICL has been approved for treating nearsightedness and astigmatism, while the Visian Hyperopic ICL, or Visian ICH, has been approved for correcting hyperopia or farsightedness. Both these products offer a more aesthetically pleasing outcome than competing technology due to their unique foldable design, which allows the placement of the lens behind the iris.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.aestheticsproductguide.com/2008/03/03/china-approves-staar-toric-and-hyperopic-icl/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

